# FDA Inspection 1003089 - Octapharma Plasma Inc. - March 02, 2017

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/b34ad25c-567f-4cde-86cd-00f5bf6f8a19
Source feed: FDA_Inspections

> FDA Inspection 1003089 for Octapharma Plasma Inc. on March 02, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1003089
- Company Name: Octapharma Plasma Inc.
- Inspection Date: 2017-03-02
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1087869 - 2019-04-16](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/9aeb6be9-5313-40e8-a36e-7177406b1fb2)
- [FDA Inspection 941603 - 2015-09-09](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/58359ce9-4149-4aad-a513-7984dc210a33)
- [FDA Inspection 856909 - 2013-10-28](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/9c060134-b8b8-40b6-9ccd-1064e3707d28)
- [FDA Inspection 761972 - 2011-12-22](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/154a1cca-5e1b-4c92-8f82-f8888fab8c20)
- [FDA Inspection 683029 - 2010-09-29](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/5192821d-864b-45a9-934b-67df650a7598)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/8cb7ed4e-1013-497a-a3da-c01096e19cb1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d